Learn more about the LymeX Diagnostics Prize at the June 16 virtual information session. The LymeX team will present an in-depth overview of the competition and answer questions.
A video recording and summary of questions and answers will be published following the session.
A prize competition to accelerate the development of Lyme disease diagnostics
Phase 1 of the LymeX Diagnostics Prize calls on scientific, technical, and clinical experts to submit innovative methods for detecting active Lyme disease infections in people. The ultimate goal of the multiphase competition is to advance the development of these diagnostics toward Food and Drug Administration review. The Phase 1 winners will receive an equal share of the $1 million Phase 1 prize pool and be invited to participate in a planned Phase 2.
Browse entrant resources
Explore fundamentals about Lyme disease, details on the LymeX partnership, tools for patient-centered design, regulatory and commercialization considerations, and more in the competition resources.
Transforming diagnostics for Lyme disease will only be possible through collaborative innovation among patients, advocates, academia, nonprofits, industry, and government. Register for the competition entrant community to identify opportunities to collaborate with others or add members to your team.
To receive all competition updates, subscribe to the LymeX Diagnostics Prize newsletter and follow @Lyme_X on Twitter.